Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa

Publisher： Karger

E-ISSN： 1662-6567|5|3|326-331

ISSN： 1662-6567

Source： Case Reports in Dermatology, Vol.5, Iss.3, 2013-11, pp. : 326-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia

By  

Case Reports in Dermatology, Vol. 3, Iss. 1, 2011-03 ,pp. : 60-63

Karger

Access to resources Recommend Favorite

Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 213-216

Karger

Access to resources Recommend Favorite

Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy

By  

Dermatology, Vol. 215, Iss. 4, 2007-10 ,pp. : 295-300

Karger

Access to resources Recommend Favorite

Lack of Association between the Promoter Polymorphisms at Positions –308 and –238 of the Tumor Necrosis Factor Alpha Gene and Psoriasis vulgaris in Japanese Patients

By  

Dermatology, Vol. 207, Iss. 4, 2004-01 ,pp. : 371-374

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite